Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women

Circulation

Volumn 103, Issue 24, 2001, Pages 2903-2908

  Vongpatanasin, Wanpen ^a   Tuncel, Meryem ^a   Mansour, Yasser ^a   Arbique, Debbie ^a   Victor, Ronald G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Hormones; Menopause; Nervous system, sympathetic

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRONE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; HYPERTENSION; POSTMENOPAUSE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 0035912856     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.24.2903     Document Type: Article

References (35)

1. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991
2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
3. Physiological doses of estradiol decrease noctural blood pressure in normotensive postmenopausal women
4. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women
5. Transdermal oestrogen reduces daytime blood pressure in hypertensive women
6. Estradiol-17B reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension
7. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy
8. The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure postmenopausal women
9. Ambulatory - Not office - Blood pressures decline during hormone replacement therapy in healthy postmenopausal women
10. Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium
11. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
12. Effects of 17β-estradiol on sympathetic activity and pressor response to phenylephrine in ovariectomized rats
13. Estrogen enhancement of baroreflex sensitivity is centrally mediated
14. Somatosensory proprioceptive and sympathetic activity in human peripheral nerves
15. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure
16. Cyclosporin-induced sympathetic activation and hypertension after heart transplantation
17. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension
18. The acute effects of sublingual 17β-estradiol on the cardiovascular system
19. Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women
20. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women
21. The variability of muscle nerve sympathetic activity in resting recumbent man
22. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure
23. Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects
24. Estrogen replacement, vascular distensibility, and blood pressures in postmenopausal women
25. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects
26. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: An in situ hybridization study
27. Induction of calcium-dependent nitric oxide synthases by sex hormones
28. The route of estrogen replacement confers divergent effects on substrate oxidation and body composition in postmenopausal women
29. Insulin-like growth factor-1 decreases sympathetic nerve activity: The effect is modulated by glycemic status
30. Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency
31. Body fat and sympathetic nerve activity in healthy subjects
32. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
33. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
34. Implications of small reductions in diastolic blood pressure for primary prevention